Goldman Sachs’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $807K | Sell |
239,459
-26,557
| -10% | -$89.5K | ﹤0.01% | 3972 |
|
|
2025
Q1 | $1.03M | Sell |
266,016
-31,113
| -10% | -$120K | ﹤0.01% | 3793 |
|
|
2024
Q4 | $1.83M | Buy |
297,129
+21,597
| +8% | +$133K | ﹤0.01% | 3537 |
|
|
2024
Q3 | $1.48M | Sell |
275,532
-328,173
| -54% | -$1.77M | ﹤0.01% | 3552 |
|
|
2024
Q2 | $2.02M | Buy |
603,705
+97,449
| +19% | +$326K | ﹤0.01% | 3180 |
|
|
2024
Q1 | $2.04M | Sell |
506,256
-517,467
| -51% | -$2.09M | ﹤0.01% | 3191 |
|
|
2023
Q4 | $2.71M | Buy |
1,023,723
+579,225
| +130% | +$1.53M | ﹤0.01% | 3012 |
|
|
2023
Q3 | $1.05M | Sell |
444,498
-2,918
| -0.7% | -$6.89K | ﹤0.01% | 3508 |
|
|
2023
Q2 | $2.82M | Buy |
447,416
+146,792
| +49% | +$925K | ﹤0.01% | 2978 |
|
|
2023
Q1 | $1.73M | Buy |
300,624
+26,153
| +10% | +$151K | ﹤0.01% | 3306 |
|
|
2022
Q4 | $2.82M | Sell |
274,471
-719,174
| -72% | -$7.38M | ﹤0.01% | 3039 |
|
|
2022
Q3 | $16.6M | Buy |
993,645
+902,408
| +989% | +$15.1M | ﹤0.01% | 1743 |
|
|
2022
Q2 | $1.28M | Sell |
91,237
-25,895
| -22% | -$362K | ﹤0.01% | 3777 |
|
|
2022
Q1 | $1.89M | Buy |
117,132
+49,294
| +73% | +$796K | ﹤0.01% | 3636 |
|
|
2021
Q4 | $1.45M | Buy |
67,838
+12,704
| +23% | +$272K | ﹤0.01% | 3737 |
|
|
2021
Q3 | $810K | Buy |
55,134
+34,056
| +162% | +$500K | ﹤0.01% | 4117 |
|
|
2021
Q2 | $419K | Sell |
21,078
-62,372
| -75% | -$1.24M | ﹤0.01% | 4517 |
|
|
2021
Q1 | $2.5M | Buy |
+83,450
| New | +$2.5M | ﹤0.01% | 3189 |
|